Elektrofi
Elektrofi develops biologic therapies through its hyper concentration microparticle platform technology, Hypercon. The company focuses on reengineering medicine delivery to support partners and patients with smarter administration methods. Elektrofi collaborates with other biopharma companies to develop new generation medicines that can be delivered subcutaneously.
Domain
elektrofi.com
Country
United StatesIndustry
Alternative MedicineEmployees
51-100
Last Funding
$112.3M
Founded
2015
Tech Stack (11 technologies)
Frequently Asked Questions
What technologies does Elektrofi use?+
Elektrofi uses 11 technologies including Adobe Fonts, reCAPTCHA, Squarespace.
What industry is Elektrofi in?+
Elektrofi operates in the Alternative Medicine industry.
Where is Elektrofi based?+
Elektrofi is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026